IGM Biosciences (IGM) is up ~40% in Wednesday morning trading as investors apparently feel the biotech could be an M&A target following Biogen's (BIIB) $1.8B deal announced earlier today for HI-Bio (...
Source LinkIGM Biosciences (IGM) is up ~40% in Wednesday morning trading as investors apparently feel the biotech could be an M&A target following Biogen's (BIIB) $1.8B deal announced earlier today for HI-Bio (...
Source Link
Comments